Halozyme Therapeutics (NASDAQ:HALO) fell 14% after confirming on Thursday that it made an €11 per share bid for Evotec (EVO).

The Angels released Zuniga on Thursday. Zuniga cleared waivers after being booted from the 40-man roster and has now been cut loose. The 26-year-old is a hard thrower but has just a 16:8 K:BB in 19.2 ...

Xbox Black Friday deals are officially live. You can snag digital versions of Pentiment, Street Fighter 6 and many other ...

The 26-year-old is Carter’s first-ever S’Auntie Claus and is partnering with the brand to celebrate auntie figures and their ...

The “Little Mermaid” actress and the rapper welcomed their son, Halo, in December 2023 and announced their split in October.

In a recent interview, Microsoft Gaming CEO Phil Spencer had some compelling things to say about the future of the Halo ...

Xbox boss Phil Spencer has left the door open for a possible Halo game to release on PlayStation 5, noting that there are now "red lines." ...

Evotec (EVO) is attracting potential takeover interest from Halozyme Therapeutics (HALO), Eyk Henning of Bloomberg reports, citing people ...

When Travis d'Arnaud signed with the Los Angeles Angels, he knew exactly what he was doing even if that meant he wouldn't be catching the majority of games in 2 ...

The $2B-plus Intuit Dome features an array of boundary-pushing fan experience aspects, but its Halo Board, the largest double-sided videoboard in an arena ever, may have the biggest impact on the ...

Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team Storage-Area Networking (SAN) DIEGO, ...

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), to bulk up its drug discovery and development portfolio.